Proteomic analysis of a penicillin-tolerant rgg mutant strain of Streptococcus pyogenes

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 4, 2006, Pages 752-759

  Chaussee, Michelle A ^a   McDowell, Emily J ^a   Rieck, Lindsey D ^a   Callegari, Eduardo A ^a   Chaussee, Michael S ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Antibiotics; Group A streptococci; Infectious diseases; Mechanisms of action; Microbial pathogenicity

Indexed keywords

ALCOHOL DEHYDROGENASE; BACTERIAL PROTEIN; CERULENIN; CHAPERONIN; ELONGATION FACTOR TU; FATTY ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); PENICILLIN G; PENICILLINASE; PENTOSE PHOSPHATE; PHOSPHOGLUCOMUTASE; PROTEIN DNAK; REGULATOR OF GLYCOSYLTRANSFERASE PROTEIN; REGULATOR PROTEIN; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; RIBOSOME PROTEIN; SUPEROXIDE DISMUTASE; TRANSFER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; DRUG EXPOSURE; DRUG TOLERANCE; FATTY ACID SYNTHESIS; GLYCOLYSIS; INHIBITION KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENTOSE PHOSPHATE CYCLE; PROTEIN ANALYSIS; PROTEOMICS; STREPTOCOCCUS PYOGENES; STRESS; TANDEM MASS SPECTROMETRY; TRANSCRIPTION REGULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WILD TYPE;

BACTERIAL PROTEINS; CULTURE MEDIA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PENICILLIN RESISTANCE; PENICILLINS; PROTEOME; STREPTOCOCCUS PYOGENES; TRANS-ACTIVATORS;

EID: 33748678701     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl319     Document Type: Article

References (49)

1. Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics - 2006 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85-151.
2. Desjardins M, Delgaty KL, Ramotar K et al. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol 2004; 42: 5620-3.
3. Sprunt K, Redman W, Leidy G. Penicillin resistant alpha streptococci in pharynx of patients given oral penicillin. Pediatrics 1968; 42: 957-68.
4. Horn DL, Zabriskie JB, Austrian R et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 1998; 26: 1341-5.
5. Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 2001; 108: 1180-6.
6. Horne D, Tomasz A. Tolerant response of Streptococcus sanguis to β-lactams and other cell wall inhibitors. Antimicrob Agents Chemother 1977; 11: 888-96.
7. Lewis K. Programmed death in bacteria. Microbiol Mol Biol Rev 2000; 64: 503-14.
8. Bayles KW. Are the molecular strategies that control apoptosis conserved in bacteria? Trends Microbiol 2003; 11: 306-11.
9. Bayles KW. The bactericidal action of penicillin: New clues to an unsolved mystery. Trends Microbiol 2000; 8: 274-8.
10. Rice KC, Firek BA, Nelson JB et al. The Staphylococcus aureus cidAB operon: Evaluation of its role in regulation of murein hydrolase activity and penicillin tolerance. J Bacteriol 2003; 185: 2635-43.
11. Groicher KH, Firek BA, Fujimoto DF et al. The Staphylococcus aureus IrgAB operon modulates murein hydrolase activity and penicillin tolerance. J Bacteriol 2000; 182: 1794-1801.
12. Brunskill EW, Bayles KW. Identification of LytSR-regulated genes from Staphylococcus aureus. J Bacteriol 1996; 178: 5810-12.
13. Novak R, Henriques B, Charpentier E et al. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999; 399: 590-3.
14. Zahner D, Kaminski K, van der Linden M et al. The ciaR/ciaH regulatory network of Streptococcus pneumoniae. J Mol Microbiol Biotechnol 2002; 4: 211-16.
15. Mascher T, Heintz M, Zähner D et al. The CiaRH system of Streptococcus pneumoniae prevents lysis during stress induced by treatment with cell wall inhibitors and by mutations in pbp2x involved in β-lactam resistance. J Bacteriol 2006: 188: 1959-68.
16. Begley M, Hill C, Ross RP. Tolerance of Listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB. Appl Environ Microbiol 2006; 72: 2231-4.
17. Lyon WR, Gibson CM, Caparon MG. A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. EMBO J 1998; 17: 6263-75.
18. Chaussee MS, Ajdic D, Ferretti JJ. The rgg gene of Streptococcus pyogenes NZ131 positively influences extracellular SPE B production. Infect Immun 1999; 67: 1715-22.
19. Chaussee MS, Watson RO, Smoot JC et al. Identification of Rgg-regulated exoproteins of Streptococcus pyogenes. Infect Immun 2001; 69: 822-31.
20. Chaussee MS, Sylva GL, Sturdevant DE et al. Rgg influences the expression of multiple regulatory loci to coregulate virulence factor expression in Streptococcus pyogenes. Infect Immun 2002; 70: 762-70.
21. Chaussee MS, Somerville GA, Reitzer L et al. Rgg coordinates virulence factor synthesis and metabolism in Streptococcus pyogenes. J Bacteriol 2003; 185: 6016-24.
22. Vickerman MM, Wang M, Baker LJ. An amino acid change near the carboxyl terminus of the Streptococcus gordonii regulatory protein Rgg affects its abilities to bind DNA and influence expression of the glucosyltransferase gene gtfG. Microbiology 2003; 149: 399-406.
23. Rawlinson EL, Nes IF, Skaugen M. Identification of the DNA-binding site of the Rgg-like regulator LasX within the lactocin S promoter region. Microbiology 2005; 151: 813-23.
24. Neely MN, Lyon WR, Runft DL et al. Role of RopB in growth phase expression of the SpeB cysteine protease of Streptococcus pyogenes. J Bacteriol 2003; 185: 5166-74.
25. Chaussee MA, Callegari EA, Chaussee MS. Rgg regulates growth phase-dependent expression of proteins associated with secondary metabolism and stress in Streptococcus pyogenes. J Bacteriol 2004; 186: 7091-99.
26. Caldelari I, Loeliger B, Langen H et al. Deregulation of the arginine deiminase (arc) operon in penicillin-tolerant mutants of Streptococcus gordonii. Antimicrob Agents Chemother 2000; 44: 2802-10.
27. Chaussee MS, Gerlach D, Yu CE et al. Inactivation of the streptococcal erythrogenic toxin B gene (speB) in Streptococcus pyogenes. Infect Immun 1993; 61: 3719-23.
28. Daneo-Moore L, Bourbeau P, Weinstein R et al. Effects of cerulenin on antibiotic-induced lysis of Streptococcus faecalis (S. faecium). Antimicrob Agents Chemother 1979; 16: 858-61.
29. Ferretti JJ, McShan WM, Ajdic D et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 2001; 98: 4658-63.
30. Peloso UC, De Souza JC, Botino MA et al. Penicillin concentrations in sera and tonsils after intramuscular administration of benzathine penicillin G to children. Pediatr Infect Dis J 2003; 22: 1075-8.
31. Heath RJ, White SW, Rock CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 2001; 40: 467-97.
32. Charpentier E, Tuomanen E. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect 2000; 2: 1855-64.
33. Tuomanen E. Phenotypic tolerance: The search for β-lactam antibiotics that kill nongrowing bacteria. Rev Infect Dis 1986; 8 Suppl 3: S279-91.
34. Singh VK, Jayaswal RK, Wilkinson BJ. Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol Lett 2001; 99: 79-84.
35. Utaida S, Dunman PM, Macapagal D et al. Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. Microbiology 2003; 149: 2719-32.
36. Weart RB, Nakano S, Lane BE et al. The CIpX chaperone modulates assembly of the tubulin-like protein FtsZ. Mol Microbiol 2005; 57: 238-49.
37. Weiss DS. Bacterial cell division and the septal ring. Mol Microbiol 2004; 54: 588-97.
38. Giesbrecht P, Karsten T, Maidhof H et al. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol Mol Biol Rev 1998; 62: 1371-414.
39. Stack HM, Sleator RD, Bowers M et al. Role for HtrA in stress induction and virulence potential in Listeria monocytogenes. Appl Environ Microbiol 2005; 71: 4241-7.
40. Brissette JL, Pieringer RA. The effect of penicillin on fatty acid synthesis and excretion in Streptococcus mutans BHT. Lipids 1985; 20: 173-9.
41. Carson DD, Pieringer RA, Daneo-Moore L. Effect of cerulenin on cellular autolytic activity and lipid metabolism during inhibition of protein synthesis in Streptococcus faecalis. J Bacteriol 1981; 146: 590-604.
42. Shungu DL, Cornett JB, Shockman GD. Lipids and lipoteichoic acid of autolysis-defective Streptococcus faecium strains. J Bacteriol 1980; 142: 741-6.
43. Rodionov DG, Ishiguro EE. Dependence of peptidoglycan metabolism on phospholipid synthesis during growth of Escherichia coli. Microbiology 1996; 142: 2871-77.
44. Kessler RE, van de Rijn I. Effects of penicillin on group A streptococci: Loss of viability appears to precede stimulation of release of lipoteichoic acid. Antimicrob Agents Chemother 1981; 19: 39-43.
45. Horne D, Hakenbeck R, Tomasz A. Secretion of lipids induced by inhibition of peptidoglycan synthesis in streptococci. J Bacteriol 1977; 132: 704-17.
46. Cleveland RF, Holtje JV, Wicken AJ et al. Inhibition of bacterial wall lysins by lipoteichoic acids and related compounds. Biochem Biophys Res Commun 1975; 67: 1128-35.
47. Cleveland RF, Wicken AJ, Daneo-Moore L et al. Inhibition of wall autolysis in Streptococcus faecalis by lipoteichoic acid and lipids. J Bacteriol 1976; 126: 192-7.
48. Holtje JV, Tomasz A. Biological effects of lipoteichoic acids. J Bacteriol 1975; 124: 1023-27.
49. Tomasz A, Waks S. Mechanism of action of penicillin: Triggering of the pneumococcal autolysic enzyme by inhibitors of cell wall synthesis. Proc Natl Acad Sci USA 1975; 72: 4162-6.